Ratification Date: 25/07/2025
Next Review Date: 25/07/2027
Quetiapine – Schizophrenia – 1st line
| Drug Name (Brand) | Quetiapine (Generics are available) | |||
| Indication | Schizophrenia – 1st line | |||
| Traffic Light Classification | Amber Initiate | |||
| NICE TA (plus link) | Overview | Psychosis and schizophrenia in adults: prevention and management | Guidance | NICE | |||
| Further Information:
NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.
Consultant initiation only. Trust will supply atypical antipsychotics for new outpatients for the first three months if there are appropriate reasons to do this, ie unstable or difficult patient, inadequate support available. NICE produced guidance on use of atypical anitpsychotics in June 2002 (TAG No. 43)
May 2009: The TAG acknowledged NICE CG 82 Psychosis and schizophrenia: management which replaced TA 43 and CG 1.
May 2014: The TAG acknowledged NICE CG 178 Psychosis and schizophrenia in adults: prevention and management ,which replaced CG 82 |
||||
| Date of TAG recommendation / ratification | 11/1/2001 | Review Date | ||